Heart Disease News and Research

Latest Heart Disease News and Research

Three pediatric cardiac hospitals to perform live cases with Toshiba's Infinix CF-i system

Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.

25 Jul 2011

Study: Mail-order pharmacy use linked to improved cardiovascular risk factor outcomes

Kaiser Permanente Northern California patients who obtained new statin prescriptions via a mail-order pharmacy achieved better cholesterol control in the first 3-15 months following the initiation of therapy -- compared to those patients who only obtained their statin prescription from their local Kaiser Permanente Northern California pharmacy.

25 Jul 2011

Intravenous fluids appear to lower severity of kidney failure in children with E. coli infection

Infection with E. coli bacteria can wreak havoc in children, leading to bloody diarrhea, fever and kidney failure. But giving children intravenous fluids early in the course of an E. coli O157:H7 infection appears to lower the odds of developing severe kidney failure, according to researchers at Washington University School of Medicine in St. Louis and other institutions.

25 Jul 2011

Large clinical trial to test new device for detecting Barrett's oesophagus

CANCER RESEARCH UK has launched a large multi-centre trial to test a new device for detecting Barrett's oesophagus - a condition that puts sufferers at increased risk of developing cancer of the oesophagus, one of the most deadly cancers.

25 Jul 2011

Janssen receives FDA Complete Response letter for SIMPONI sBLA to treat RA

Janssen Biotech, Inc. announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response letter for its supplemental Biologics License Application (sBLA) for SIMPONI.

25 Jul 2011

Rats, fish oil and beetroot juice could lead to health breakthroughs for aging populations

Though rats, fish oil and beetroot juice read like ingredients in a witch's brew, to a Kansas State University research team, information from this combination could lead to health breakthroughs for aging populations and people suffering from heart failure and diabetes.

22 Jul 2011

U.S. News ranks Ronald Reagan UCLA Medical Center among top five American hospitals

Ronald Reagan UCLA Medical Center ranks among the top five American hospitals, according to a U.S. News & World Report survey that reviewed patient-outcomes data, reputation among physicians and other care-related factors. The medical center also was rated the best hospital in the western United States for the 22nd consecutive year and the No. 1 hospital in the Los Angeles metropolitan area.

22 Jul 2011

Modern Plastics moves to Shelton, Connecticut

Modern Plastics, one of the largest distributors of high-performance and engineering-grade stock shapes and medical-grade plastics, has moved from its former home in Bridgeport to Shelton, Connecticut. The new address is 88 Long Hill Cross Road, Shelton, Connecticut 06484 USA.

22 Jul 2011

Research roundup: Restricting Medigap coverage; Hospital-acquired infections

Increases In Mortality, Length Of Stay, And Cost Associated With Hospital-Acquired Infections In Trauma Patients -- This study explores the clinical and economic burden of hospital-acquired infections, the most common complication in hospitalized patients, for trauma patients.

22 Jul 2011

Anesthesia-associated mortality rises again

In pure numerical terms, anesthesia-associated mortality has risen again. The reasons for this are the disproportionate increase in the numbers of older and multimorbid patients and surgical procedures that would have been unthinkable in the past.

22 Jul 2011

Health Canada approves SPRYCEL as first-line treatment for life-threatening blood cancer

Canadians newly diagnosed with a life-threatening blood cancer, chronic myeloid leukemia (CML) in chronic phase, now have a new treatment option available to them. Health Canada has granted a notice of compliance with conditions for SPRYCEL (dasatinib) as first-line treatment in patients with chronic phase CML.

22 Jul 2011

UCSF, Kaiser Permanente achieve first major milestone in genomics project

One of the nation's largest and most diverse genomics projects has reached its first major milestone in just 15 months. Scientists have genotyped the DNA and analyzed the length of chromosome tips in more than 100,000 Kaiser Permanente members who agreed to be part of the research.

22 Jul 2011

Michigan Cardiovascular Institute performs first Astron Pulsar stent procedure in the U.S.

BIOTRONIK announced today that the first endovascular procedure was completed in the BIOFLEX-I clinical trial—a trial set to evaluate the safety and performance of the Astron and Astron Pulsar self-expanding peripheral stents.

22 Jul 2011

The Joint Commission certifies 7 disease-specific programs at Children's Medical Center

The Joint Commission has certified seven disease-specific programs at Children's Medical Center Dallas, www.childrens.com. Children's is the only pediatric hospital in the United States with more than two such designations of excellence, making the Dallas hospital a leader in health care reform.

22 Jul 2011

FDA approves U.S. launch of Wiskott-Aldrich gene therapy clinical trial

The U.S. Food & Drug Administration (FDA) approved the launching in the U.S. of a clinical trial for gene therapy for a rare immunodeficiency, Wiskott-Aldrich syndrome.

22 Jul 2011

Montifiore's surgeons receive certification training for implanting total artificial heart

A surgical team from the Montefiore Einstein Center for Heart and Vascular Care recently received certification training for implanting the SynCardia Total Artificial Heart, a replacement heart implanted in patients at risk of imminent death from heart failure.

22 Jul 2011

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

Janssen Biotech, Inc., formerly Centocor Ortho Biotech Inc., announced today that the Gastrointestinal Drugs Advisory Committee of the U.S. Food and Drug Administration recommended the approval of REMICADE for the treatment of moderately to severely active ulcerative colitis in pediatric patients who have had an inadequate response to conventional therapy.

22 Jul 2011

Heart Disease News and Research

Latest Heart Disease News and Research

Three pediatric cardiac hospitals to perform live cases with Toshiba's Infinix CF-i system

Study: Mail-order pharmacy use linked to improved cardiovascular risk factor outcomes

Intravenous fluids appear to lower severity of kidney failure in children with E. coli infection

Large clinical trial to test new device for detecting Barrett's oesophagus

Janssen receives FDA Complete Response letter for SIMPONI sBLA to treat RA

Rats, fish oil and beetroot juice could lead to health breakthroughs for aging populations

U.S. News ranks Ronald Reagan UCLA Medical Center among top five American hospitals

Modern Plastics moves to Shelton, Connecticut

Research roundup: Restricting Medigap coverage; Hospital-acquired infections

Anesthesia-associated mortality rises again

Health Canada approves SPRYCEL as first-line treatment for life-threatening blood cancer

UCSF, Kaiser Permanente achieve first major milestone in genomics project

Michigan Cardiovascular Institute performs first Astron Pulsar stent procedure in the U.S.

The Joint Commission certifies 7 disease-specific programs at Children's Medical Center

FDA approves U.S. launch of Wiskott-Aldrich gene therapy clinical trial

Montifiore's surgeons receive certification training for implanting total artificial heart

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

Leading cancer specialists and researchers establish Australia’s first comprehensive ‘Cancer Survivors Centre’

BioMedix receives U.S. patent titled, 'System and Method for Testing for Cardiovascular Disease'

U.S. News recognizes HUMC among top 50 hospitals nationally in three specialties

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Heart Disease News and Research

Latest Heart Disease News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in